Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04119960 · ClinicalTrials.gov registry record
Clinical Validation of InferRead Lung CT.AI
A clinical trial of Lung Cancer, sponsored by Infervision.
- Completed
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT04119960: Completed study of Lung Cancer, sponsored by Infervision.
NCT04119960 is a study of Lung Cancer that has completed, run by Infervision. The registered enrollment target is 250 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04119960, a study of Lung Cancer, has completed, sponsored by Infervision.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
Lung cancer is the second most common cause of cancer-related death in men and women. Early pulmonary nodule screening is an effective means to prevent lung cancer, which is no less important than the diagnosis and treatment of lung cancer. Early lung cancer screening has been investigated and applied as a medical practice. InferRead Lung CT.AI by Infervision is a dedicated post processing application that generates CADe marks as an overlay on the original CT series intended to aid the radiologist in the detection of pulmonary nodules. This study was designed to evaluate radiologists' performance in detecting actionable nodules on chest CT when aided by InferRead.
Conditions Studied
Interventions
- DEVICE Aided read with InferRead Lung CT.AI
Study Locations (1)
Maryland
- University of Maryland Medical Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2019-01-10 |
| Est. Completion | 2019-10-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04119960
The ClinicalTrials.gov registry entry for NCT04119960 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (73% lower). The listed sponsor is Infervision, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Aided read with InferRead Lung CT.AI is the first listed.
NCT04119960 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT04119960 about?
NCT04119960 is a clinical study titled "Clinical Validation of InferRead Lung CT.AI". Lung cancer is the second most common cause of cancer-related death in men and women. Early pulmonary nodule screening is an effective means to prevent lung cancer, which is no less important than the diagnosis and treatment of lung cancer. Early lung cancer screening has been investigated and appli...
What is the current status of trial NCT04119960?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2019-01-10. Estimated completion is 2019-10-30.
What conditions does trial NCT04119960 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT04119960?
The interventions under investigation include: Aided read with InferRead Lung CT.AI (DEVICE).
Who is sponsoring clinical trial NCT04119960?
This trial is sponsored by Infervision, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04119960 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.